CD31

[Theranostics] Researchers reported on non-invasive longitudinal imaging of the wound healing process in transgenic mice overexpressing vascular endothelial growth factor (VEGF) A in keratinocytes by means of large-scale optoacoustic microscopy.

[Scientific Reports] Researchers investigated the potential of CSC differentiation into blood cells under chemical hypoxic conditions using CoCl2. CSCs and miPS-LLCcm cells were cultured for one to seven days in the presence of CoCl2, and the expression of VEGFR1/2, Runx1, c-kit, CD31, CD34, and TER-119 was assessed by RT-qPCR, Western blotting and flow cytometry together with Wright-Giemsa staining and immunocytochemistry.

[Experimental Cell Research] To explore the role of human umbilical cord mesenchymal stem cells (hucMSCs) in inhibiting endothelial inflammation in Kawasaki disease (KD), the effects of hucMSCs on the expression of CD54 and CD105 in endothelial cells in KD were analyzed in vivo and in vitro.

[Cardiovascular Research] NOX1 mediated endothelial activation and contributed to myocardial inflammation and remodeling in metabolic disease in mice. Given its high expression in monocytes of humans with diastolic dysfunction (DD), NOX1 may represent a potential target to mitigate heart disease associated with DD.

[Scientific Reports] Researchers proposed that cardiomyocyte-driven paracrine signaling, which likely involves Notch1, directs subsequent trans-differentiation of endo- and epicardial cells.

[Cell Death & Disease] Natriuretic peptide receptor A protected HIF-1α from proteolysis by binding to HIF-1α, increased the expression of HIF-1α, and promoted gastric cancer angiogenesis.